Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis (BIOSEP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03302806
Recruitment Status : Completed
First Posted : October 5, 2017
Last Update Posted : September 21, 2021
Information provided by (Responsible Party):
Nantes University Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 4, 2017
Actual Study Completion Date : October 24, 2018